Takemasa Tsuji

5PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2024
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs.

Bowen Dong, Nataša Obermajer, Takemasa Tsuji

|Nov 22, 2023
Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity.

Hao Fan, Siyuan Xia, Junhong Xiang

|Oct 23, 2023
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans.

Alexandra V Vylegzhanina, Ivan A Bespalov, Ksenia A Novototskaya-Vlasova

|Mar 16, 2022
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.

Kunle Odunsi, Feng Qian, Amit A Lugade

Pageof 1